Literature DB >> 25388278

Deformation density components analysis of fullerene-based anti-HIV drugs.

Sara Fakhraee1, Maryam Souri.   

Abstract

Deformation density analysis is performed on fullerene-based anti-HIV agents to investigate the influence of charge redistribution on the capability of binding to HIV enzymes. Two types of HIV inhibitors including malonic acid- and amino acid-type C60 derivatives are considered to study. Total deformation density and its components including orbital relaxation and kinetic energy pressure are obtained for C60 derivatives. The deformation natural orbitals for each component of deformation density are assessed and their amounts of charge displacement are quantified to evaluate the binding affinity of HIV inhibitors. The results show that the orbital relaxation plays a more prominent role in deformation of electron density of studied compounds. Among the considered drugs, the amino acid-type derivatives, N-(carboxymethyl)-2,5-dicarboxylic fulleropyrrolidines, show the most charge displacement. Moreover, the investigation into the deformation density of amino acid-type functional groups on C60 reveals that the connection of functional groups to the 5,6-ring junction results more displaced charge than the connection to the 6,6-ring junction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25388278     DOI: 10.1007/s00894-014-2486-z

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  21 in total

1.  NCIPLOT: a program for plotting non-covalent interaction regions.

Authors:  Julia Contreras-García; Erin R Johnson; Shahar Keinan; Robin Chaudret; Jean-Philip Piquemal; David N Beratan; Weitao Yang
Journal:  J Chem Theory Comput       Date:  2011-03-08       Impact factor: 6.006

2.  Semiempirical GGA-type density functional constructed with a long-range dispersion correction.

Authors:  Stefan Grimme
Journal:  J Comput Chem       Date:  2006-11-30       Impact factor: 3.376

3.  Of atoms, mountains, and stars: a study in qualitative physics.

Authors:  V F Weisskopf
Journal:  Science       Date:  1975-02-21       Impact factor: 47.728

4.  Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.

Authors:  Serdar Durdagi; Thomas Mavromoustakos; Nikos Chronakis; Manthos G Papadopoulos
Journal:  Bioorg Med Chem       Date:  2008-10-22       Impact factor: 3.641

5.  Revealing noncovalent interactions.

Authors:  Erin R Johnson; Shahar Keinan; Paula Mori-Sánchez; Julia Contreras-García; Aron J Cohen; Weitao Yang
Journal:  J Am Chem Soc       Date:  2010-05-12       Impact factor: 15.419

6.  C60-Fullerene monomalonate adducts selectively inactivate neuronal nitric oxide synthase by uncoupling the formation of reactive oxygen intermediates from nitric oxide production.

Authors:  D J Wolff; K Mialkowski; C F Richardson; S R Wilson
Journal:  Biochemistry       Date:  2001-01-09       Impact factor: 3.162

7.  Buckyballs meet viral nanoparticles: candidates for biomedicine.

Authors:  Nicole F Steinmetz; Vu Hong; Erik D Spoerke; Ping Lu; Kurt Breitenkamp; M G Finn; Marianne Manchester
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

8.  Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation.

Authors:  S H Friedman; P S Ganapathi; Y Rubin; G L Kenyon
Journal:  J Med Chem       Date:  1998-06-18       Impact factor: 7.446

9.  Synthesis and anti-HIV properties of new water-soluble bis-functionalized[60]fullerene derivatives.

Authors:  Susanna Bosi; Tatiana Da Ros; Giampiero Spalluto; Jan Balzarini; Maurizio Prato
Journal:  Bioorg Med Chem Lett       Date:  2003-12-15       Impact factor: 2.823

Review 10.  Medicinal applications of fullerenes.

Authors:  Rania Bakry; Rainer M Vallant; Muhammad Najam-ul-Haq; Matthias Rainer; Zoltan Szabo; Christian W Huck; Günther K Bonn
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.